EGFR and non-small cell lung carcinoma: The adjusted multivariable Cox regression analysis revealed a positive direction of the hazard of death for EGFR-mutant NSCLC (HR 1.07, 95% CI: 0.48–2.39, p = 0.87); see Supplementary Table S2.